SQL 6.6 (+0%)
US81734C1062Medical Diagnostics & ResearchDiagnostics & Research

SeqLL (SQL) Competitor Comparison

We are evaluating the key criteria listed to compare SeqLL (SQL) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - SQL ranking 39 / 58

These are the competitors of SeqLL in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
151.8
2. Illumina ILMN
58.47
3. Inotiv NOTV
56.91
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. Guardant Health GH
20.11
6. National Research NRC
9.96
7. Anixa Biosciences ANIX
9.39
8. Olink Holding OLK
8.11
9. Pacific Biosciences of California PACB
6.47
10. Myriad Genetics MYGN
5.81
11. Global Cord Blood CO
5.67
12. Sotera Health SHC
4.95
13. DarioHealth DRIO
4.86
14. Fulgent Genetics FLGT
4.1
15. Bioventus BVS
4.04
16. Sera Prognostics SERA
3.73
17. Syneos Health SYNH
3.71
18. Co-Diagnostics CODX
3.31
19. Enzo Biochem ENZ
3.09
20. NeoGenomics NEO
2.88
21. Psychemedics PMD
2.86
22. Qiagen QGEN
2.67
23. Twist Bioscience TWST
2.57
24. Aspira Womens Health AWH
2.28
25. Exagen XGN
2.25
26. Meridian Bioscience VIVO
2.1
27. MDxHealth MDXH
2.05
28. Biodesix BDSX
2.01
29. MaxCyte MXCT
1.9
30. Personalis PSNL
1.89
31. Prenetics Global PRE
1.81
32. bioAffinity Technologies BIAF
1.78
33. Exact Sciences EXAS
1.78
34. Organovo Holdings ONVO
1.66
35. Neuronetics STIM
1.62
36. Trinity Biotech TRIB
1.57
37. Charles River Laboratories CRL
1.52
38. Laboratory Corp of America Holdings LH
1.47
39. SeqLL SQL
1.42
40. Quest Diagnostics DGX
1.38
41. Interpace Biosciences IDXG
1.27
42. DexCom DXCM
1.18
43. CareDx CDNA
1.15
44. PerkinElmer PKI
1.15
45. Precipio PRPO
1.09
46. Waters WAT
0.79
47. Agilent Technologies A
0.69
48. IQVIA Holdings IQV
0.69
49. Heska HSKA
0.52
50. IDEXX Laboratories IDXX
0.45
51. RadNet RDNT
0.43
52. Thermo Fisher Scientific TMO
0.42
53. Natera NTRA
0.41
54. Mettler-Toledo MTD
0.41
55. Lantheus Holdings LNTH
0.39
56. Icon ICLR
0.38
57. Danaher DHR
0.34
58. Medpace Holdings MEDP
0.23

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.